Stamford, Connecticut, United States
Our Deloitte Strategy & Transactions team helps guide clients through their most critical moments and transformational initiatives. We offer comprehensive end-to-end support and advisory services, covering areas such as valuation modeling, cost optimization, restructuring, business design and transformation, infrastructure and real estate, mergers and acquisitions (M&A), and sustainability. The team works closely with clients at every stage of their journey, helping them navigate challenges, avoid financial pitfalls, and implement practical solutions before, during, and after major transformational projects or transactions creating lasting impact.
Join Deloitte’s Performance Improvement & Restructuring Offering (PI&R) and help life sciences clients unlock liquidity, improve cash flow, and strengthen working capital performance in a sector defined by innovation, regulatory complexity, and rapid growth. As a Working Capital Senior Manager, you will advise leading companies, investors, and stakeholders on high-impact challenges, translating operational complexity into measurable cash and value creation.
Work You’ll Do
As a Working Capital Senior Manager in Turnaround & Restructuring, part of PI&R, you will be responsible for helping Life Sciences clients improve liquidity, optimize cash flow, and address complex operational and financial challenges.
A successful candidate would possess these skills:
The Team
PI&R defines and leads enterprise Board and C-Suite agendas for non-distressed, underperforming, and distressed clients to improve margins, operational and financial performance, navigate financial difficulties, and improve cashflow to fund critical transformations.
Within Deloitte’s Turnaround & Restructuring practice and broader PI&R Offering, the Working Capital team helps clients improve liquidity and release cash through targeted operational and financial improvements. The team works across areas such as receivables, payables, inventory, procurement, and process performance, using data-driven insights and practical execution support to help clients strengthen cash generation, improve efficiency, and create sustainable value. Our practice also works with companies, acquirers and private equity firms, to identify value creation opportunities that exist within companies or a potential acquisition candidate to improve business process performance and release excess cash from working capital. Whether it involves debt restructuring, asset divestitures, or operational realignment, Deloitte’s working capital professionals’ goal is to help our clients emerge stronger.
An evolving customer and regulatory landscape, mounting pipeline of next-gen assets and portfolio pressures, and intensifying competition are presenting new organizational and operational hurdles for Life Sciences companies. These complex market dynamics are requiring new levels of rigor and insight in business strategy development and problem-solving, both domestically and globally. Throughout the health ecosystem, you’ll find courageous and inspiring people who are committed to driving transformation, advancing health equity, and leading a well-being revolution. Where you find innovators committed to sustainable progress, you’ll find Deloitte’s Life Sciences & Health Care practice. Our leaders work side-by-side to orchestrate and deliver on the business of science and health. We bring trusted, flexible approaches that help foster innovation, harness new technologies, and formulate consumer-driven strategies to engineer a digitally enabled, equitable future of health – starting today.
Qualifications
Required:
Preferred: